AAAAAA
Results:
1-12
|
Results: 12
Authors:
Ladetto, M
Sametti, S
Astolfi, M
Corradini, P
Ricca, I
Drandi, D
Pileri, A
Tarella, C
Citation: M. Ladetto et al., Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting, LEUK LYMPH, 40(5-6), 2001, pp. 679-682
Authors:
Tarella, C
Cuttica, A
Caracciolo, D
Zallio, F
Ricca, I
Bergui, L
Gavarotti, P
Marinone, C
Pagano, M
Rossi, G
de Crescenzo, A
Salomone, A
Ladetto, M
Boccadoro, M
Pileri, A
Citation: C. Tarella et al., High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments, ANN HEMATOL, 80, 2001, pp. B123-B126
Authors:
Tarella, C
Zallio, F
Caracciolo, D
Cuttica, A
Corradini, P
Gavarotti, P
Ladetto, M
Podio, V
Sargiotto, A
Rossi, G
Gianni, AM
Pileri, A
Citation: C. Tarella et al., High-dose mitoxantrone plus melphalan (MITO/L-PAM) as conditioning regimensupported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity, LEUKEMIA, 15(2), 2001, pp. 256-263
Authors:
Ladetto, M
Sametti, S
Donovan, JW
Ferrero, D
Astolfi, M
Mitterer, M
Ricca, I
Drandi, D
Corradini, P
Coser, P
Pileri, A
Gribben, JC
Tarella, C
Citation: M. Ladetto et al., A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients, EXP HEMATOL, 29(2), 2001, pp. 183-193
Authors:
Ladetto, M
Bergui, L
Ricca, I
Campana, S
Pileri, A
Tarella, C
Citation: M. Ladetto et al., Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients, MED ONCOL, 17(3), 2000, pp. 203-210
Authors:
Ladetto, M
Donovan, JW
Harig, S
Weller, E
Trojan, A
Poor, C
Schlossman, R
Anderson, KC
Gribben, JG
Citation: M. Ladetto et al., Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma, BIOL BLOOD, 6(3), 2000, pp. 241-253
Authors:
Trojan, A
Schultze, JL
Witzens, M
Vonderheide, RH
Ladetto, M
Donovan, JW
Gribben, JG
Citation: A. Trojan et al., Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies, NAT MED, 6(6), 2000, pp. 667-672
Authors:
Tarella, C
Caracciolo, D
Corradini, P
Zallio, F
Ladetto, M
Cuttica, A
Rossi, G
Novero, D
Gavarotti, P
Pileri, A
Citation: C. Tarella et al., Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft, LEUKEMIA, 14(4), 2000, pp. 740-747
Authors:
Donovan, JW
Ladetto, M
Zou, GY
Neuberg, D
Poor, C
Bowers, D
Gribben, JG
Citation: Jw. Donovan et al., Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia, BLOOD, 95(8), 2000, pp. 2651-2658
Authors:
Tarella, C
Corradini, P
Astolfi, M
Bondesan, P
Caracciolo, D
Cherasco, C
Ladetto, M
Giaretta, F
Ricca, I
Vitolo, U
Pileri, A
Ferrero, D
Citation: C. Tarella et al., Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions, LEUKEMIA, 13(9), 1999, pp. 1456-1462
Authors:
Corradini, P
Ladetto, M
Pileri, A
Tarella, C
Citation: P. Corradini et al., Clinical relevance of minimal residual disease monitoring in non-Hodgkin'slymphomas: a critical reappraisal of molecular strategies, LEUKEMIA, 13(11), 1999, pp. 1691-1695
Authors:
Corradini, P
Voena, C
Tarella, C
Astolfi, M
Ladetto, M
Palumbo, A
Van Lint, MT
Bacigalupo, A
Santoro, A
Musso, M
Majolino, I
Boccadoro, M
Pileri, A
Citation: P. Corradini et al., Molecular and clinical remissions in multiple myeloma: Role of autologous and allogeneic transplantation of hematopoietic cells, J CL ONCOL, 17(1), 1999, pp. 208-215
Risultati:
1-12
|